2015 Antineoplastics

Example hematopoiesis test questions

Q1. Which of the following chemical classes of drugs...

Answer

Q2. In the ABVD regimen, doxorubicin and dacarbazine...
Q3. If the resistance the cancer cells have developed...
Q4. Identify the correct match...
Q5. Some forms of lung cancer exhibit primary resistance to gefitinib...
Q6. Which of the following is the BEST description...
Q7. An antineoplastic drug preferentially kills proliferating cells,...
Q8. Which of the following would be MOST likely to INCREASE ...
Q9. A patient with metastatic colorectal cancer is being treated...
Q10. Which of the following would you be MOST likely to see...
Q11. Which of the following is the MOST likely reason for development of resistance...
Q12. A patient with acute myeloid leukemia is being treated with gemtuzumab ...
Q13. Identify the drug, occasionally still used in the treatment of chronic myeloid leukemia (CML)...
Q14. Which of the following will INCREASE the effectiveness of cyclophosphamide...
Q15. Which of the following side effects is LEAST likely to be experienced by a breast cancer patient ...
Q16. Which of the following can result from the use of melphalan?
Q17. Which of the following actions of anthracycline antibiotics...
Q18. Drug A inhibits the enzymes at both sites 1 and 2...
Q19. A recent study has shown that 95% of patients with...
Q20. Which of the following is NOT a mechanism of action...
Q21. In this combination regimen,...
Q22. Which of the following is this patient LEAST likely to experience?
Q23. A cancer becomes resistant to vinblastine. Which of the following...
Q24. Which drug has the longest half-life?
Q25. One reason that methotrexate (MTX) followed by leucovorin...
   
   
   
   
   
   
   
   
Email: Dr. Janet Fitzakerley | ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM